Proxy-Objective Misspecification in AI-Guided Design of Targeted Nanocarriers: Why Optimising Predicted Affinity Can Reduce Therapeutic Selectivity
IIAR Journal of Pharmaceutical Sciences · 27.10.2026 · 1 (1)
DOI: 10.68854/53kg2y69 ↗Kurz gefasst
Fachartikel in der Zeitschrift IIAR Journal of Pharmaceutical Sciences, online erschienen am 27.10.2026. Verfasst von Igwe Emmanuel Sunday und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sunday, I. E., Chinecherem, N. I., & Usulor, N. E. (2026). Proxy-Objective Misspecification in AI-Guided Design of Targeted Nanocarriers: Why Optimising Predicted Affinity Can Reduce Therapeutic Selectivity. IIAR Journal of Pharmaceutical Sciences, 1(1). https://doi.org/10.68854/53kg2y69
Vancouver
Sunday IE, Chinecherem NI, Usulor NE. Proxy-Objective Misspecification in AI-Guided Design of Targeted Nanocarriers: Why Optimising Predicted Affinity Can Reduce Therapeutic Selectivity. IIAR Journal of Pharmaceutical Sciences. 2026;1(1). doi:10.68854/53kg2y69
BibTeX
@article{Sunday2026,
author = {Sunday, Igwe Emmanuel and Chinecherem, NWEKE Isaac and Usulor, NWOGBOJI Emmanuel},
title = {Proxy-Objective Misspecification in AI-Guided Design of Targeted Nanocarriers: Why Optimising Predicted Affinity Can Reduce Therapeutic Selectivity},
journal = {IIAR Journal of Pharmaceutical Sciences},
year = {2026},
volume = {1},
number = {1},
doi = {10.68854/53kg2y69}
}
EUVIMED